2-(4-nitropyrazol-1-yl)-1-(5-pyridin-2-yl-3,6-dihydro-2H-pyridin-1-yl)ethanone
C15H15N5O3 — CID 122141664
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-nitropyrazol-1-yl)-1-(5-pyridin-2-yl-3,6-dihydro-2H-pyridin-1-yl)ethanone
2-(4-nitropyrazol-1-yl)-1-(5-pyridin-2-yl-3,6-dihydro-2H-pyridin-1-yl)ethanone (PubChem CID 122141664) has the molecular formula C15H15N5O3 and a molecular weight of 313.32 g/mol. Its IUPAC name is 2-(4-nitropyrazol-1-yl)-1-(5-pyridin-2-yl-3,6-dihydro-2H-pyridin-1-yl)ethanone.
Molecular Properties
| Compound Name | 2-(4-nitropyrazol-1-yl)-1-(5-pyridin-2-yl-3,6-dihydro-2H-pyridin-1-yl)ethanone |
|---|---|
| PubChem CID | 122141664 |
| Molecular Formula | C15H15N5O3 |
| Molecular Weight | 313.32 g/mol |
| Exact Mass | 313.12 |
| IUPAC Name | 2-(4-nitropyrazol-1-yl)-1-(5-pyridin-2-yl-3,6-dihydro-2H-pyridin-1-yl)ethanone |
| SMILES | O=C(Cn1cc([N+](=O)[O-])cn1)N1CCC=C(c2ccccn2)C1 |
| InChI | InChI=1S/C15H15N5O3/c21-15(11-19-10-13(8-17-19)20(22)23)18-7-3-4-12(9-18)14-5-1-2-6-16-14/h1-2,4-6,8,10H,3,7,9,11H2 |
| InChIKey | KXTWIKPRSNSQCC-UHFFFAOYSA-N |
| XLogP | 1.50 |
| TPSA | 94.16 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 313.32 |
| LogP ≤ 5 | 1.50 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122141664 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.